Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Livomyn-FL
- Development stage
- Unknown
- Lead developer
- Charak
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Livomyn-FL is an oral, tablet-form nutraceutical developed by Charak for daily liver wellness and metabolic liver support. It is formulated with a combination of clinically studied active ingredients, including Silymarin (milk thistle extract), Resveratrol, N-Acetylcysteine (NAC), and Kalmegh (Andrographis paniculata). Livomyn-FL is designed to support hepatocyte protection, maintain healthy liver enzymes (such as AST and ALT), provide antioxidant defense, and support metabolic liver function in adults, particularly those with metabolic risk factors, steatosis, early-stage hepatic fibrosis, or elevated liver enzymes associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
- Brand names
- Livomyn-FL
- Other names
- Livomyn-FL Tablet
02
Targets
GSH (Glutathione)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)
Beyond the preview
Go deeper on Livomyn-FL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Livomyn-FL.